Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Aneta Mikulasova.

Newcastle AuthorsTitleYearFull text
Hannah Smith
Francesco Kumara Mastrorosa
Dr Giles Holt
Dr Brendan Houston
Dr Bilal Alobaidi
et al.
A de novo paradigm for male infertility2022
Dr Aneta Mikulasova
Chromosomal abnormalities in multiple myeloma2022
Dr Aneta Mikulasova
Dr Lisa Russell
Dr Daniel Rico Rodriguez
Dynamics of broad H3K4me3 domains uncover an epigenetic switch between cell identity and cancer-related genes2022
Dr Aneta Mikulasova
Dan Kent
Dr Marco Trevisan-Herraz
Nefeli Karataraki
Kent Fung
et al.
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers2022
Dr Simon Bomken
Dr Amir Enshaei
Dr Ed Schwalbe
Dr Aneta Mikulasova
Dr Masood Zaka
et al.
Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement2022
Dr Aneta Mikulasova
Novel de novo pathogenic variant in the GNAI1 gene as a cause of severe disorders of intellectual development2022
Dr Aneta Mikulasova
Case Report: Contiguous Xq22.3 Deletion Associated with ATS-ID Syndrome: From Genotype to Further Delineation of the Phenotype2021
Dr Preeti Singh
Maninder Heer
Dr Anastasia Resteu
Dr Aneta Mikulasova
Dr Mojgan Reza
et al.
GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS12021
Dr Aneta Mikulasova
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis2021
Dr Daniel Leongamornlert
Dr Aneta Mikulasova
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities2021
Dr Jarmila Spegarova
Dr Karin Engelhardt
Dr Helen Griffin
Dr Aneta Mikulasova
Dr Meghan Acres
et al.
Germline TET2 loss-of-function causes childhood immunodeficiency and lymphoma2020
Dr Aneta Mikulasova
Professor Graham Jackson
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma2020
Dr Christopher Duncan
Dr Benjamin Thompson
Dr Rui Chen
Dr Florian Gothe
Victoria Shuttleworth
et al.
Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT22019
Dr Aneta Mikulasova
A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance2017
Dr Aneta Mikulasova
Professor Graham Jackson
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma2017
Dr Aneta Mikulasova
Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM)2016
Dr Aneta Mikulasova
Genome-wide profiling of copy‑number alteration in monoclonal gammopathy of undetermined significance2016
Dr Aneta Mikulasova
Analysis of B-cell subpopulations in monoclonal gammopathies2015
Dr Aneta Mikulasova
Professor Graham Jackson
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma2015
Dr Aneta Mikulasova
Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience2014
Dr Aneta Mikulasova
Incidence of cytogenetic aberrations in two B lineage subpopulations in multiple myeloma patients analyzed by combination of whole-genome profiling and FISH2014